Skip to content

Editors

Harry Cassin
Publisher and Editor

Andy Spalding
Senior Editor

Jessica Tillipman
Senior Editor

Bill Steinman
Senior Editor

Richard L. Cassin
Editor at Large

Elizabeth K. Spahn
Editor Emeritus

Cody Worthington
Contributing Editor

Julie DiMauro
Contributing Editor

Thomas Fox
Contributing Editor

Marc Alain Bohn
Contributing Editor

Bill Waite
Contributing Editor

Russell A. Stamets
Contributing Editor

Richard Bistrong
Contributing Editor

Eric Carlson
Contributing Editor

DOJ declination for Bristol-Myers Squibb

Bristol-Myers Squibb said in a securities filing that the DOJ closed its FCPA investigation into the company and won’t bring an enforcement action.

In early October, Bristol-Myers Squibb paid $14.7 million to resolve charges by the SEC that its joint venture in China made cash payments and gave other benefits to health care providers at state-owned and state-controlled hospitals in exchange for prescription sales.… Continue Reading